Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control. (2017)

First Author: Barbieri I
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.18619

Publication URI: https://www.repository.cam.ac.uk/handle/1810/271626

Type: Journal Article/Review